Table 1 Case studies regarding the impact of different perspectives on incremental cost-effectiveness ratios relating to interventions in Vietnam
From: An overview of the perspectives used in health economic evaluations
Intervention and chosen perspective | Cost per DALY averted (US$) |
|---|---|
Wolbachia deployments to control dengue (compared to the status quo) [41] | Â |
Health care provider perspective | 708.21 |
Health sector perspective | 419.56 |
Societal perspective (excluding the productivity gains related to prevented excess mortality) | Dominates the comparator |
Societal perspective | Dominates the comparator |
Rotavirus vaccination (compared to no vaccination) [42] | Â |
Healthcare system perspective | 1777 |
Societal perspective (only including the productivity costs related to caregivers' time spent caring for sick children) | 1744 |
Haemophilus influenzae type b (Hib) vaccination (compared to no vaccination) [43] | Â |
Governmental perspective | 1850 |
Societal perspective (excluding the productivity gains related to prevented excess mortality) | 1662 |
Values were adjusted for inflation to 2020 US$ (using GDP deflators pertaining to Vietnam [44, 45]) | Â |